|
|
|
|
Vol. 58, Issue 6, 1222-1229, December 2000
Department of Medicine and the Cancer Center, University of California, San Diego, La Jolla, California
| |
Abstract |
|---|
|
|
|---|
This study focused on the question of how the DNA mismatch
repair (MMR) system and p53 interact to maintain genomic integrity in
the presence of the mutagenic stress induced by hydrogen peroxide (H2O2). The cytotoxic and mutagenic effects of
H2O2 were compared in four colon carcinoma
sublines: HCT116, HCT116/E6, HCT116+ch3, and HCT116+ch3/E6,
representing MMR
/p53+,
MMR
/p53
, MMR+/p53+,
and MMR+/p53
phenotypes, respectively. Loss
of p53 in MMR-proficient cells did not significantly alter cellular
sensitivity to H2O2, but disruption of p53 in
MMR-deficient cells resulted in substantial resistance to
H2O2 (IC50 values of 203.8 and 66.2 µM for MMR
/p53
and
MMR
/p53+ cells, respectively). The effect of
loss of p53 and MMR function on sensitivity to the mutagenic effect of
H2O2 paralleled the effects on cytotoxic
sensitivity. In MMR-deficient cells, loss of p53 resulted in a 3.5- and
2.2-fold increase in the generation of 6-thiogunaine and
ouabain-resistant clones, respectively. Loss of MMR in combination with
loss of p53 synergistically increased the frequency of frameshift
mutations in the CA repeat tracts of the out-of-frame shuttle vector
pZCA29 and further promoted instability of microsatellite sequences
under H2O2 stress. Flow cytometric analysis
showed that H2O2 treatment produced a
Gl and G2/M phase arrest in
MMR+/p53+ cells. Loss of MMR did not alter the
ability of H2O2 to activate either checkpoint;
loss of p53 in either the MMR-proficient or deficient cells resulted in
impairment of the Gl arrest and a more pronounced
G2/M arrest. H2O2 caused a greater
and more longed increase in p53 protein levels in MMR-proficient than
in the MMR-deficient cells. The results demonstrate that the effect of
disabling p53 function is modulated by the proficiency of the MMR
system (and vice versa) and that there is an overlap between the
functions of p53 and the MMR system with respect to the activation of
apoptosis and mutagenesis after an oxidative stress.
| |
Introduction |
|---|
|
|
|---|
Cells
engage multiple repair mechanisms after DNA damage, reflecting the
importance of DNA repair in maintaining both cell viability and genomic
stability (ap Rhys and Bohr, 1996
). Among these, the postreplicative
DNA mismatch repair (MMR) system is of particular importance to the
integrity of the genome. In addition to its role in correcting the
misincorporation errors that occur during replication, MMR is also
implicated in the recognition of several types of DNA damage. We and
others have demonstrated that loss of MMR causes resistance to the
cytotoxic effects of some of the platinum-containing drugs (Anthoney et
al., 1996
; Drummond et al., 1996
; Fink et al., 1996
) and renders cells
hypersensitive to the mutagenic effects of cisplatin (Lin and Howell,
1999
). One hypothesis is that MMR acts as a sensor for genomic damage that, upon recognition of certain types of DNA lesions, initiates a
sequence of events that facilitate repair or promote apoptosis (Kat et
al., 1993
; Hawn et al., 1995
; Nehmé et al., 1997
).
The p53 protein plays a central role in the cellular injury response
after DNA damage (Lane, 1992
). After DNA damage, wild-type p53
activates several genes that lead to cell-cycle arrest, DNA repair, or
apoptosis. Some of these genes include
p21WAF1/CIP1, GADD45, and MDM2 (El-Deiry et al.,
1993
; Chen et al., 1994
; Zhan et al., 1994
). Current evidence is
consistent with the hypothesis that loss of p53 contributes to genomic
instability by permitting the inappropriate survival of cells that
would normally have undergone apoptosis in response to DNA damage.
Reactive oxygen species are formed continuously in living cells as
byproducts of normal cellular metabolism, as well as through the action
of exogenous compounds and radiation. Adducts produced by oxidative
damage may constitute the single most common type of DNA damage, and it
has been estimated that each human cell must repair approximately
10,000 oxidatively damaged sites in its genome each day (Ames, 1989
).
It is a generally accepted that DNA damage derived from molecular
oxygen occurs largely through the generation of
H2O2 (DiGiuseppi and
Fridovich, 1984
). H2O2 is
clearly mutagenic in bacteria (Levin et al., 1982
), and there is
substantial evidence that endogenously generated
H2O2 is mutagenic in
mammalian cells (Hsie et al., 1986
; Ziegler-Skylakakis and Andrae,
1987
; Oller and Thilly, 1992
; Gille et al., 1994
). The induction of
mutations after oxidative stress represents a failure of the available
repair systems to remove the DNA damage, and such mutations are
believed to contribute to malignant transformation.
Heterozygosity with respect to germline mutations that disable the
function of either p53 or any of several genes whose products play
central roles in MMR predisposes to malignancy. It is likely that
genomic instability caused by loss of either p53 or MMR plays a role in
the phenomenon of tumor progression and the acquisition of drug
resistance after the cell has become fully malignant. Mutations in p53
are found in more than 50% of all human tumors (Hollstein et al.,
1991
). Loss of MMR is characteristic of tumors arising in patients with
hereditary nonpolyposis colon cancer and is also found in some cases of
sporadic cancer of many types. Loss of p53 or MMR function in at least
a subset of the cells in a tumor because of somatic mutation is even
more likely. In the present work, we have used sublines of the human
colon carcinoma cell line HCT116 that have been engineered to differ in
MMR capacity and p53 function to investigate the interaction of p53
with MMR in modulating the cellular sensitivity to the cytotoxic and
mutagenic effects of oxidative stress imposed by
H2O2.
| |
Experimental Procedures |
|---|
|
|
|---|
Cell Lines.
The hMLH1-deficient human colorectal
adenocarcinoma cell line HCT116 was obtained from the American Type
Culture Collection (Manassas, VA); HCT116 contains a hemizygous
mutation in hMLH1 resulting in a truncated, nonfunctional protein
(Boyer et al., 1995
). A subline complemented with chromosome 3 (HCT116+ch3) was obtained from Drs. C.R. Boland and M. Koi. The
chromosome 3-complemented cells are competent in DNA mismatch repair
(Koi et al., 1994
). HCT116 and HCT116+ch3 sublines expressing
papillomavirus E6 (identified here as HCT116/E6 and HCT116+ch3/E6) were
obtained from Drs. D.A. Boothman and M. Meyers. p53 function was
disrupted in these cell lines by constitutive high-level expression of
the human papillomavirus type-16 E6 gene, which stimulates the
degradation of p53 through a ubiquitin pathway (Davis et al., 1998
).
All the four cell lines were maintained in Iscove's modified
Dulbecco's medium (Irvine Scientific, Irvine, CA) supplemented with 2 mM L-glutamine and 10% heat-inactivated fetal bovine
serum. The chromosome-complemented lines were maintained in medium
containing 400 µg/ml geneticin (Life Technologies, Inc.,
Gaithersburg, MD), and the cell lines expressing papillomavirus E6 were
cultured in medium supplemented with 80 µg/ml hygromycin B
(Boehringer Mannheim, Indianapolis, IN).
Materials. In these studies, oxidative stress was generated by exposing cells to exogenously added hydrogen peroxide. Hydrogen peroxide was obtained as a 30% solution from Sigma Chemical Co. (St. Louis, MO) and diluted freshly with serum-free medium to form a stock solution of 50 mM before each experiment. The H2O2 solution was filter sterilized before addition to cell cultures.
Clonogenic Assay. Clonogenic assays were performed by seeding 250 cells into 60-mm plastic dishes in 5 ml of complete media. After a 24-h incubation at 37°C, the cultures were replaced with serum-free medium and appropriate amounts of hydrogen peroxide were added to the dishes and incubated for 1 h. After treatment with H2O2, cells were rinsed twice at 37°C in PBS to remove any remaining H2O2 and fresh medium was added. Colonies of at least 50 cells were scored visually after 8 to 10 days. Each experiment was performed a minimum of three times using triplicate cultures for each drug concentration. IC50 values were determined using log-linear interpolation.
Mutant Frequency Assay. HCT116, HCT116/E6, HCT116+ch3, and HCT116+ch3/E6 cells were grown in HAT medium containing 0.4 µM aminopterin, 16 µM thymidine, and 100 µM hypoxanthine for a minimum of 14 days and were then exposed for 1 h to increasing concentrations of H2O2 in serum-free medium. Thereafter, the cells were washed twice and recultured in regular medium for 8 days during which the cultures were split 2:1 as needed to keep them from becoming confluent. All the cells were then trypsinized and seeded into each of 10 100-mm tissue culture dishes at 100,000 cells/dish in the presence of 20 µM 6-thioguanine. At the same time, aliquots of 250 cells were seeded into each of three 60-mm dishes in drug-free medium for determination of cloning efficiency. After 14 days, colonies were counted after staining with 0.1% crystal violet. The procedure for determination of the frequency of mutation to ouabain was the same except that the cells were not grown in HAT medium before the start of the experiments, and the ouabain concentration was 1.0 µM. Mutation frequency was calculated as follows: mutation frequency = a/(b × 106) where "a" is the number of colonies present in the 10 drug-treated dishes and "b" is the cloning efficiency. Each experiment was performed a minimum of three times and the data are presented as mean ± S.D.
Host Cell Microsatellite Instability Assay.
The pZCA29
vector (Diem and Runger, 1998
) was obtained from Dr. Runger. Four
million HCT116, HCT116/E6, HCT116+ch3, HCT116+ch3/E6 cells were
transfected with 2 µg of pZCA29 by electroporation on day 1. Replicated pZCA29 was recovered from the transfected cells on days 3, 5, 7, 9, and 11 by a rapid alkali lysis procedure. For the
H2O2 treatment experiment,
2 days after transfection, the cells were treated with 100 µM
H2O2 for 1 h, and the
vector harvested on days 3, 5, 7, 9, and 11. Unreplicated input plasmid DNA was removed by digestion with DpnI, which cleaves the
methylated DNA from bacteria. Escherichia coli XL1- Blue
MRF' (Stratagene) was transformed with recovered pZCA29 and then
selected on LB agar plates containing
5-bromo-4-chloro-3-indolyl-
-galactosidase, isopropyl-
-D-thiogalactoside, and ampicillin.
Bacterial transformations were performed in triplicate for each of two
to three independent samples of pZCA29 recovered at each time point.
The total number of white and blue colonies were counted. The mutation
frequency was calculated as the mean of the total number of blue
colonies divided by the mean of the total number of colonies.
Student's t test was used to test for the differences.
Flow Cytometry. Subconfluent cultures growing in 10-cm tissue culture dishes were exposed to 100 µM H2O2 for 1 h. At 1, 2, and 3 days after H2O2 treatment, cells were harvested by trypsinization, washed twice with ice-cold PBS, fixed in ice-cold 70% ethanol, treated with RNase (Sigma) at 37°C for 30 min, and stained with 50 µg/ml propidium iodide (Sigma). After a 30-min incubation on ice, the cells were analyzed on a FACScan flow cytometer (Becton-Dickinson, San Jose, CA) using the FlowJo cell cycle analysis software (Tree Star, Inc., San Carlos, CA) and the "Watson Pragmatic" model.
Western Blotting. Cells were collected at times from 1 to 7 days after a 1-h treatment with 100 µM H2O2, and lysed in 100 µl of lysis buffer [10 mM Tris·HCl, pH7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 5 mM dithiothreitol, 1 mM sodium vanadate, 0.1 mM phenylmethylsulfonyl fluoride, and 5 mM aminocaproic acid] for 30 min on ice. The insoluble material was removed by centrifugation at 14,000 g for 20 min at 4°C. Ten micrograms of protein from each sample were electrophoresed through 10 to 20% SDS-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane (Immobilon P; Millipore, Bedford, MA). The membranes were blotted with p53 monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA). After application of a horseradish peroxidase-coupled secondary antibody, reactive proteins were visualized with enhanced chemiluminescence (Amersham Pharmacia Biotech, Piscataway, NJ). The protein bands that reacted with the antibodies were detected on radiographic film (Fuji Medical X-ray Film; Fuji Medical Systems USA, Stamford, CT) 5 to 60 s after exposure. The bands of p53 on radiographic films were scanned and analyzed densitometrically by a ChemiImager (Alpha Innotech Corporation, San Leandro, CA).
| |
Results |
|---|
|
|
|---|
Effect of Loss of p53 and/or MMR Function on the Cytotoxicity of
H2O2.
These studies were conducted using a
panel of four human colon carcinoma HCT116 sublines engineered to have
the following combinations of proficient and deficient phenotypes:
p53+/MMR+,
p53
/MMR+,
p53+/MMR
, and
p53
/MMR
. Clonogenic
assays were used to determine the effect of loss of p53, MMR, or both
on the sensitivity to the cytotoxic effects of
H2O2. The
H2O2 concentration-survival
curves for the 4 HCT116 sublines are shown in Fig.
1, and the IC50
values and statistical analyses are presented in Table
1. The
p53+/MMR+ cells were the
most sensitive. Loss of p53 function because of the expression of E6
reduced sensitivity by a factor of 1.3-fold, whereas loss of MMR in
these cells reduced sensitivity by 1.5-fold. However, loss of both p53
and MMR function rendered the cells 4.5-fold resistant. Thus, loss of
p53 function in MMR-proficient cells had relatively little effect on
sensitivity to H2O2,
whereas loss of p53 function in MMR-deficient cells had a substantially larger effect (3.1-fold).
|
|
Effect of Loss of p53 and/or MMR Function on the Ability of
H2O2 to Generate Drug-Resistant Variants.
As one measure of mutagenesis, cells were exposed to
H2O2 for 1 h, and then
the number of 6-thioguanine and ouabain-resistant clones in the
surviving population was measured 10 days later. Figure
2 shows that the number of 6-thioguanine
and ouabain-resistant colonies increased linearly as a function of
H2O2 concentration in all
four HCT116 sublines over the range tested. Sensitivity to the
mutagenic effect of H2O2
was determined from the slope of the plot of the number of resistant
colonies per 106 clonogenic cells and
H2O2 concentration. Based
on the ratio of the slopes, as shown in Table 1, loss of p53 function
alone increased the generation of 6-thioguanine-and ouabain-resistant
variants by 1.6- and 1.3-fold, respectively. Loss of MMR function alone increased the ability of
H2O2 to generate
6-thioguanine and ouabain-resistant variants by only 1.4- and 1.3-fold,
respectively. Loss of both p53 and MMR resulted in a 4.9-fold increase
in the generation of 6-thioguanine-resistant variants and a 3.0-fold
increase in the generation of ouabain-resistant variants. Thus, whereas
loss of p53 in the MMR-proficient cells had relatively little effect, loss of p53 in the MMR-deficient cells resulted in a large increase in
slope of 3.5- and 2.2-fold for 6-thioguanine and ouabain, respectively. Thus, the impact of the loss of one type of genome stabilizing function
was modulated by whether the cell was proficient or deficient with
respect to the other function. The effect of loss of p53 and MMR
function on sensitivity to the mutagenic effect of
H2O2 closely paralleled the
effects on cytotoxic sensitivity.
|
Effect of Loss of p53 and/or MMR Function on the Ability of
H2O2 to Generate Insertion/Deletion
Mutants.
Another way to assess the effect of loss of p53 or MMR
function on sensitivity to the mutagenic potential of
H2O2 is to measure its
ability to produce insertion/deletion mutations in a defined DNA
sequence. This was approached by comparing the stability of a
microsatellite sequence introduced into the four HCT116 sublines in the
form of an episomally replicating shuttle vector. The pZCA29 vector
contains a 94-base pair (bp) insertion, that includes within it a 28-bp
CA repeat tract and a 30-bp GT repeat tract arranged palindromically
that renders the coding sequences of a
-galactosidase reporter gene
out of frame. The vector also contains the simian virus 40 T-antigen,
origin, and enhancer to allow episomal replication in the human
cells. In the absence of a frameshift mutation generated during
replication of the vector in the tumor cell,
-galactosidase is not
expressed when the plasmid is rescued from the mammalian cell and
introduced into an appropriate bacterial strain. However, insertions or
deletions introduced during replication of the vector in the tumor
cells that correct the reading frame permit expression of
-galactosidase when the vector is transferred to the bacteria. The
fraction of the plasmids containing such a mutation after passage
through the tumor cells can be quantified as the fraction of blue
versus white bacterial colonies.
,
MMR
/p53+, and
MMR
/p53
cell lines for
various periods of time. These frequencies reflect the ability of the
cell to faithfully replicate the out-of-frame vector under basal
conditions in the absence of any exogenous oxidative insult. For each
cell line, the number of mutations increased as a function of the time
during which the vector was allowed to replicate in the tumor cells.
Differences between the cell lines were apparent after just 3 days of
vector replication. Based on the slope of the plot of mutant frequency
versus time, generation of mutants was lowest for the MMR and
p53-proficient cell line. Loss of p53 function alone increased the
mutant frequency by 1.6-fold, whereas loss of MMR alone increased it by
1.2-fold relative to the
MMR+/p53+ cells. However,
the greatest increase, 2.4-fold, was observed in the cells that had
lost both p53 and MMR function. This increase was statistically
significant for comparison with either the
MMR+/p53+ cells or cells
that had lost either just p53 or MMR function alone. Thus, the pZCA29
vector detected the type of genomic instability produced by both loss
of p53 and loss of MMR; these results indicate that both types of loss
produced instability in the microsatellite sequence contained in this
vector.
|
H2O2-Induced Cell Cycle Arrest.
As a first step toward elucidation of the mechanisms responsible for
the differences in sensitivity to the cytotoxic and mutagenic effects
of H2O2, we sought to
determine how loss of p53 alone, MMR alone, or both functions together
altered the ability of H2O2 to activate the G1 and G2/M
cell cycle control checkpoints. As shown in Fig.
4,
H2O2 induced a marked and
sustained G2/M phase arrest in the
MMR+/p53+ cells; 54.7% of
these cells were arrested in G2/M at 24 h,
53.4% at 48 h, and 53.0% at 72 h. Only a gradual decay in
the fraction of cells in G1 was seen over this
time range. In contrast, there was no change in the fraction of control
untreated cells in G2/M over this time frame with
only 23.5% in this phase of the cell cycle at 72 h (data not
shown). Loss of p53 alone resulted in an increase in the fraction of
cells arrested in G2/M after
H2O2 treatment to a level
further above that observed in the
MMR+/p53+ cells. It also
resulted in a rapid loss of cells from G1
consistent with inactivation of the Gl
checkpoint. Loss of MMR function alone did not reduce the ability of
H2O2 to engage the
G2/M arrest mechanism, although the arrest was
not as sustained as in the
MMR+/p53+ cells. Loss of
MMR alone also did not affect the fraction of cells in
G1 at various time points compared with the
MMR+/p53+ cells. Loss of
both p53 and MMR function together produced a profile very similar to
that associated with the loss of p53 alone, except that there was an
even greater accumulation of cells in G2/M and a
more pronounced loss of cells from G1. Thus, the
loss of p53 function due to the expression of E6 produced largely
similar effects in both MMR-proficient and deficient cells.
|
Effect of H2O2 on p53 Protein Level.
Fig. 5 demonstrates that the 1 h
exposure to 100 µM H2O2
induced an increase in p53 protein level in the p53- and MMR-proficient cells that was sustained for at least 6 days. In cells that had lost
MMR alone, there was a smaller increase in p53 level than was observed
in the fully proficient subline, and this was sustained for a shorter
period of time. Expression of E6 reduced the level of p53 and
completely abolished the
H2O2-induced increase in
both the P53
/MMR+ and
p53
/MMR
sublines (data
not shown). As a control, the cells were also examined for the ability
of cisplatin to induce an increase in p53 protein level. The same type
of deficit was observed for cisplatin as well. Thus, loss of MMR
function partially impaired activation of the signal transduction
pathway that mediates the change in p53 protein level after two
different types of DNA damage, both of which are detectable by the MMR
system.
|
| |
Discussion |
|---|
|
|
|---|
Mutations that disable p53 are frequently found in human cancers
(Hollstein et al., 1991
), often in association with tumor progression
or high grade malignancy (Carder et al., 1993
). Loss of MMR function is
a less common but well-described phenomenon, particularly in colon and
endometrial cancer (Fishel et al., 1993
; Leach et al., 1993
; Nicolaides
et al., 1994
; Papadopoulos et al., 1994
). The fact that many malignant
cells have defects in genomic stability is of concern with respect to
continued accumulation of somatic mutations that result in tumor
progression and drug resistance.
H2O2 is generated as a
byproduct of normal cellular metabolism. Although it is a potent
mutagen, detoxification and DNA repair mechanisms normally prevent the
accumulation of oxidatively damaged bases in DNA. The results of this
study demonstrate that, in human colon carcinoma cells, loss of either
p53 or MMR function alone reduces the cytotoxicity and increases the
mutagenicity of H2O2; most
importantly, however, there is an interaction between loss of these two
functions. Loss of either p53 or MMR function alone produced
unequivocal but relatively modest changes in sensitivity to the
cytotoxic and mutagenic effect of
H2O2, but loss of both together produced much larger effects on both parameters. As depicted schematically in Fig. 6, the net result
is that a given exposure to
H2O2 produced more
mutations, and the mutated cells had a higher probability of surviving
to replicate again. Thus, the risk of the generation and persistence of
clones carrying mutations capable of contributing to tumor progression
or the emergence of drug resistance is increased.
|
The extent to which endogenously generated
H2O2 actually drives the
generation of somatic mutations in tumor cells is uncertain. However,
the results of this study indicate that the risk of such somatic
mutations is increased when both p53 and MMR function are lost. This
has already been documented for an exogenous mutagen. Previous studies
from this laboratory demonstrated that p53 and MMR-deficient cells are
hypersensitive to the ability of cisplatin to generate variants in the
population that are resistant to several different classes of other
chemotherapeutic agents (Lin and Howell, 1999
; Lin et al., 1999
, 2000
).
The current study did not investigate the nature of the interaction
between loss of p53 and MMR. That is, it cannot be determined from the
studies reported here whether the interaction is truly synergistic,
only additive, or even partially antagonistic. This would require a
formal mathematical approach such as the use of isobologram or median
effect analysis (Photiou et al., 1997
). However, it is clear that
H2O2 is more cytotoxic and
mutagenic when both functions are disabled. Caution is also needed in
interpreting the result of E6 expression to be caused entirely by the
loss of p53 function, because E6 can affect other proteins in the cell
as well.
How does loss of p53 and MMR function cause resistance to the cytotoxic
effect of H2O2?
Particularly at low concentrations, H2O2 is believed to kill by
activating apoptosis; thus, it is reasonable to hypothesize that both
p53 and MMR play a role in generating the apoptotic response that
follows excessive oxidative damage. As depicted schematically in Fig.
6, these roles are likely to be in different but partially redundant
pathways, because disabling both functions produced a larger effect
than disabling either one alone. p53 and MMR may function at the level
of DNA damage recognition, checkpoint activation, or at one or more
points in the sequence of signaling events that communicate the
presence of excessive DNA damage to the apoptotic machinery. The
central role of p53 in mediating activation of the caspase cascade
after DNA damage has been extensively reported and reviewed in recent years (Wyllie, 1997
; Houghton, 1999
). It is perhaps not surprising that
p53 mediates part of the pro-apoptotic signal generated by H2O2 injury. Among the many
types of damage done to DNA by
H2O2, 8-oxoguanine seems to
play an important role in the resulting mutagenesis (Bessho et al.,
1992
; Demple and Harrison, 1994
). During DNA replication, 8-oxoguanine
can pair with cytosine or adenine with an almost equal efficiency and
transversions are common. The ability of the MMR system to recognize
and remove this altered and mismatched base has now been well
documented (McGoldrick et al., 1995
; DeWeese et al., 1998
; Jackson et
al., 1998
; Zhang et al., 1998
). The fact that loss of MMR substantially impaired the ability of
H2O2 to signal an increase
in p53 level indicates that not only are the MMR proteins capable of
binding to an 8-oxoguanine mismatch, but also that the MMR system plays an active role in the generation of an injury signal. Interestingly, although loss of MMR resulted in a blunted induction of p53, this was
not accompanied by much reduction in the ability of
H2O2 to kill cells,
suggesting that other detectors that generate pro-apoptotic signals via
p53-independent pathways must be involved as well.
What is the mechanism by which loss of either p53 or MMR causes
H2O2 to be more mutagenic?
Activation of the Gl checkpoint in p53-proficient
cells may permit repair of most the adducts produced by
H2O2 before the cell enters
S phase (Fig. 6). Failure of this checkpoint in p53-deficient cells is
likely to result in more cells entering S with a burden of unrepaired
damage. Recent reports have disclosed that there are mammalian DNA
polymerases that can bypass adducts in DNA, producing mutations as they
do so (Paz-Elizur et al., 1996
; Smith et al., 1998
; Eckert and Opresko, 1999
). T7 DNA polymerase exo- can also cause mutagenic bypass of
8-oxoguanine, the major adduct produced by
H2O2 (Furge and Guengerich,
1997
, 1998
). Both p53 and MMR may play a role in preventing such
mutagenic bypass replication (Vaisman et al., 1998
; McGregor, 1999
).
Alternatively, mutations may be introduced during the gap-filling step
after processing of the adduct by one or another of the DNA repair
mechanisms if the fidelity of the polymerases is impaired in the
absence of p53 or MMR.
Evidence for a direct role for the p53 protein in several different
types of DNA repair is accumulating rapidly. Wild-type protein, but not
mutant p53 protein, has been shown to bind strongly to a conserved
element in the GADD45 gene. A p53-containing nuclear factor, which
binds to this element, can be detected in extracts from irradiated
cells (Kastan et al., 1992
). Wang et al. (1995)
reported that p53 can
bind to several proteins known to play roles in nucleotide excision
repair, including XPD (Rad3) and XPB, as well as CSB, which is involved
in strand-specific nucleotide excision repair. With respect to MMR,
Scherer et al. (1996)
showed that wild-type p53 can directly bind to
and trans-activate the promoter of the hMSH2 gene.
More recently, Vikhanskaya et al. (1999)
demonstrated an interaction
between p53 function and MMR with respect to sensitivity to the
DNA-damaging agent cisplatin. They reported that loss of p53 in
MMR-proficient cells had little effect on cisplatin cytotoxicity but
that loss of p53 in MMR-deficient cells rendered the cells quite
hypersensitive to the drug. Very recently, Tanaka et al. (2000)
reported that p53 regulates the transcription of a catalytic subunit of
ribonucleotide reductase, an enzyme essential to the supply of
deoxynucleotides for DNA repair.
Loss of p53 and MMR permitted
H2O2 to produce more
6-thioguanine and ouabain-resistant clones. Whether these clones were
true stable mutants was not determined, but the results of the studies with the pZCA29 vector indicate that loss of p53 and MMR is permissive with respect to the frameshift mutations that this vector is designed to report. Generalized instability in microsatellites is a hallmark of
the loss of MMR function in human tumors. Such microsatellite instability is not characteristically found in tumors that have lost
just p53. Nevertheless, loss of p53 is associated with a higher
frequency of frameshift mutations even though they are not specifically
targeted to microsatellite sequences (Liu et al., 1996
). Thus, it is
not surprising that the pZCA29 vector reported a higher frequency of
mutations in p53-deficient as well as MMR-deficient cells. Inferring
from effects on the generation of 6-thioguanine and ouabain-resistant
variants, and the frameshift mutations reported by the pZCA29 vector,
the cells that survive H2O2
exposure are likely to carry an increased burden of mutations throughout their genome. Insertion/deletion mutations, such as those
detected by pZCA29, are particularly devastating to the cell because
they shift the reading frame of the coding sequence in which they
occur, resulting in completely nonfunctional sequence downstream of the
mutation, and often the creation of novel protein sequences in the cell.
Are the levels of oxidative damage produced by the exposures to
H2O2 that were used in
these experiments relevant to the oxidative stress to which tumor cells
are subjected while growing in vivo? Measurable changes in both the
cytotoxicity and mutagenicity of H2O2 were observable with
1 h exposures to concentrations as low as 20 µM. Many types of
mammalian cells generate generous amount of
H2O2, which produces
concentrations in the range of 3 to 15 µM in their local environment
(Chance et al., 1979
; Giulivi et al., 1994
) and inflammatory cells
infiltrating into tumors can produce substantially higher
concentrations (Satrowski and Nathan, 1991
). Thus, it is likely that
the endogenous levels of
H2O2 are high enough, under
some circumstances, that loss of MMR and p53 can place cells at
increased risk for mutagenesis.
| |
Acknowledgments |
|---|
We gratefully acknowledge Dr. T.M. Runger for kindly providing the plasmid shuttle vector pZCA29 and technical guidance.
| |
Footnotes |
|---|
Received April 18, 2000; Accepted September 1, 2000
This work was supported in part by Grant CA78648 from the
National Institutes of Health and conducted in part by the Clayton Foundation for Research
California Division. X.L. and S.B.H. are Clayton Foundation investigators. A preliminary account of this work
was presented at the 1999 DNA Repair and Mutagenesis Meeting of the
American Society for Microbiology.
Send reprint requests to: Stephen B. Howell, MD, Department of Medicine 0058, University of California, San Diego, La Jolla, CA 92093. E-mail: showell{at}ucsd.edu
| |
Abbreviations |
|---|
MMR, DNA mismatch repair; bp, base pair.
| |
References |
|---|
|
|
|---|
5')-thymidine.
J Biol Chem
273:
21933-2.
C:G transversions.
Nucleic Acids Res
26:
4669-4675.This article has been cited by other articles:
![]() |
F. Mayer, H. Stoop, G. L. Scheffer, R. Scheper, J. W. Oosterhuis, L. H. J. Looijenga, and C. Bokemeyer Molecular Determinants of Treatment Response in Human Germ Cell Tumors Clin. Cancer Res., February 1, 2003; 9(2): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Akyuz, G. S. Boehden, S. Susse, A. Rimek, U. Preuss, K.-H. Scheidtmann, and L. Wiesmuller DNA Substrate Dependence of p53-Mediated Regulation of Double-Strand Break Repair Mol. Cell. Biol., September 1, 2002; 22(17): 6306 - 6317. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Karran Mechanisms of tolerance to DNA damaging therapeutic drugs Carcinogenesis, December 1, 2001; 22(12): 1931 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Niedner, R. Christen, X. Lin, A. Kondo, and S. B. Howell Identification of Genes That Mediate Sensitivity to Cisplatin Mol. Pharmacol., December 1, 2001; 60(6): 1153 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kondo, R. Safaei, M. Mishima, H. Niedner, X. Lin, and S. B. Howell Hypoxia-induced Enrichment and Mutagenesis of Cells That Have Lost DNA Mismatch Repair Cancer Res., October 1, 2001; 61(20): 7603 - 7607. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Glaab, R. B. Hill, and T. R. Skopek Suppression of spontaneous and hydrogen peroxide-induced mutagenesis by the antioxidant ascorbate in mismatch repair-deficient human colon cancer cells Carcinogenesis, October 1, 2001; 22(10): 1709 - 1713. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||